Table of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022 – 2033
2.3 Market Size & Forecast, By Segmentation, 2022 – 2033
2.3.1 Market Size By Product
2.3.2 Market Size By Animal Type
2.3.3 Market Size By Application
2.3.4 Market Size By End-use
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material & Animal Breeders
3.4.2 Model Developers & Customization Service Providers
3.4.3 Distributors/Suppliers
3.4.4 End-Users (CROs, Pharma, Academia)
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview (Preclinical Research Tools/Services)
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Pricing & Cost Analysis
4.1.1 Overview: Standard vs. Custom/Genetically Engineered Models
4.1.2 Average Cost Per Model by Complexity (e.g., Inbred, Knockout, Humanized)
4.1.3 Total Cost of Ownership Analysis: Acquisition, Breeding, and Maintenance
4.1.4 Price Benchmarking by Key Species (Mice, Rats, Others)
4.1.5 Forecasted Price Trends: Impact of CRISPR and Advanced Technologies
4.2 Regulatory & Ethical Landscape Metrics
4.2.1 Overview
4.2.2 Number of IACUC Protocols & Animal Usage Approvals by Region/Year
4.2.3 Adoption Rate of Alternative Methods (3Rs Principle) by Application Area
4.2.4 Compliance & Inspection Metrics: Key Regulatory Bodies (AAALAC, USDA)
4.2.5 Future Outlook: Gene Editing Guidelines and Transgenic Model Oversight
4.3 Innovation & Pipeline Metrics
4.3.1 Overview
4.3.2 Number of New Genetically Engineered Models Developed Annually (By Technology: CRISPR, ES Cell, etc.)
4.3.3 Average Development Timeline for a New Custom Animal Model
4.3.4 Success Rate & Utilization Metrics of Models by Therapeutic Area (Oncology, Immunology, CNS)
4.3.5 Pipeline of Humanized and Patient-Derived Xenograft (PDX) Models in Development
4.4 Demand & Utilization Metrics
4.4.1 Overview
4.4.2 Annual Model Usage Volume by Key End-user Segment (Pharma, CRO, Academia)
4.4.3 Model Outsourcing Rate (%) vs. In-House Breeding by Pharmaceutical Companies
4.4.4 Share of Revenue from Standard Breeding vs. Custom Model Generation Services
4.4.5 Growth Rate in Demand for Specific-Pathogen-Free (SPF) and Immunodeficient Models
5. Animal Model Market Segmental Analysis & Forecast, By Product, 2022 – 2033, Value (USD Million)
5.1 Introduction
5.2 Rats
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2033
5.3 Mice
5.4 Guinea Pigs
5.5 Rabbits
5.6 Hamsters
5.7 Others
6. Animal Model Market Segmental Analysis & Forecast, By Animal Type, 2022 – 2033, Value (USD Million)
6.1 Introduction
6.2 Inbred
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2033
6.3 Outbred
6.4 Genetically Engineered
6.5 Hybrid
6.6 Surgically Modified
6.7 Spontaneous Mutant
7. Animal Model Market Segmental Analysis & Forecast, By Application, 2022 – 2033, Value (USD Million)
7.1 Introduction
7.2 Cancer
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2033
7.3 Immunological Disease
7.4 Infectious Disease
7.5 Neurological Disorders
7.6 Cardiovascular Diseases
7.7 Diabetes
7.8 Others
8. Animal Model Market Segmental Analysis & Forecast, By End-use, 2022 – 2033, Value (USD Million)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2033
8.3 Academic & Research Institutes
8.4 Contract Research Organizations (CROs)
8.5 Others
9. Animal Model Market Segmental Analysis & Forecast By Region, 2022 – 2033, Value (USD Million)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Animal Model Market Size & Forecast, By Product, 2022 – 2033
9.2.3 Animal Model Market Size & Forecast, By Animal Type, 2022 – 2033
9.2.4 Animal Model Market Size & Forecast, By Application, 2022 – 2033
9.2.5 Animal Model Market Size & Forecast, By End-use, 2022 – 2033
9.2.6 Animal Model Market Size & Forecast, By Country, 2022 – 2033
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Animal Model Market Size & Forecast, By Product, 2022 – 2033
9.3.3 Animal Model Market Size & Forecast, By Animal Type, 2022 – 2033
9.3.4 Animal Model Market Size & Forecast, By Application, 2022 – 2033
9.3.5 Animal Model Market Size & Forecast, By End-use, 2022 – 2033
9.3.6 Animal Model Market Size & Forecast, By Country, 2022 – 2033
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Animal Model Market Size & Forecast, By Product, 2022 – 2033
9.4.3 Animal Model Market Size & Forecast, By Animal Type, 2022 – 2033
9.4.4 Animal Model Market Size & Forecast, By Application, 2022 – 2033
9.4.5 Animal Model Market Size & Forecast, By End-use, 2022 – 2033
9.4.6 Animal Model Market Size & Forecast, By Country, 2022 – 2033
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Animal Model Market Size & Forecast, By Product, 2022 – 2033
9.5.3 Animal Model Market Size & Forecast, By Animal Type, 2022 – 2033
9.5.4 Animal Model Market Size & Forecast, By Application, 2022 – 2033
9.5.5 Animal Model Market Size & Forecast, By End-use, 2022 – 2033
9.5.6 Animal Model Market Size & Forecast, By Country, 2022 – 2033
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Animal Model Market Size & Forecast, By Product, 2022 – 2033
9.6.3 Animal Model Market Size & Forecast, By Animal Type, 2022 – 2033
9.6.4 Animal Model Market Size & Forecast, By Application, 2022 – 2033
9.6.5 Animal Model Market Size & Forecast, By End-use, 2022 – 2033
9.6.6 Animal Model Market Size & Forecast, By Country, 2022 – 2033
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Charles River Laboratories International, Inc.
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 The Jackson Laboratory
10.6.3 Taconic Biosciences, Inc.
10.6.4 Envigo (Inotiv)
10.6.5 Janvier Labs
10.6.6 Crown Bioscience International
10.6.7 genOway S.A.
10.6.8 Harbour Antibodies BV
10.6.9 Hera BioLabs
10.6.10 Champions Oncology, Inc.
10.6.11 Horizon Discovery Group (PerkinElmer)
10.6.12 Ingenious Targeting Laboratory
10.6.13 TransGenic Inc.
10.6.14 PolyGene AG
10.6.15 Vitalstar Biotechnology Co., Ltd.
10.6.16 Shanghai Model Organisms Center, Inc.
10.6.17 Beijing Vital River Laboratory Animal Technology Co., Ltd.
10.6.18 GemPharmatech Co., Ltd.
10.6.19 Cyagen Biosciences Inc.
10.6.20 GenOway (Cegav Group)
10.6.21 Ozgene Pty Ltd
10.6.22 InGenious Targeting Laboratory, Inc.
10.6.23 Sage Labs (now part of Horizon Discovery)
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
